Skip to main content
Equibles

ALTHE · THERACLION · Investor Relations

Use ALTHE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALTHE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.6300 EUR 15-min delayed · Oct 8, 10:19 UTC
Rebalance outlook locked
Market Cap
52.90M EUR
Shares
73.78M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-16 Theraclion – Half-year results 2026 – Theraclion prepares for a new stage in its development Results publication
2026-09-16 Financial results for the first half of 2026 Results publication
2026-07-09 Theraclion strengthens its governance by appointing Vincent Gardès as chairman of its board of directors Event
2026-06-04 First clinical deployment of Sonovein® in Hainan, China Event
2026-05-11 Theraclion announces the strong success of its oversubscribed capital increase Event
2026-04-16 2025 financial results Results publication
2026-01-29 Theraclion delivers a structuring year in 2025 and prepares to scale up Event
2025-10-21 Theraclion secures key Chinese certification, advancing toward market access in China Event
2025-09-15 Theraclion announces successful U.S. FDA pivotal study with 96.8% occlusion rate Event
2025-07-25 Revenue for the First Half of 2025 Event
2025-03-26 Theraclion completes its previous financing round with an additional convertible bonds issuance Event
2025-02-07 Publication of adjusted accounts for the first half of 2024 Event
2024-09-06 Theraclion confirms strong mid-year achievements Event
2024-04-25 Theraclion releases its 2023 financial report (in French) Event
2024-03-27 Financial results 2023 Event
2023-12-14 Theraclion delivers its 2023 strategic objectives Event
2023-07-31 Theraclion executes strategy in first half Event
2023-04-28 Theraclion announces 2022 financial results and informs on the company’s short-term financing Event
2023-01-16 Theraclion reaches major milestones in 2022, paving the way for the commercial deployment of SONOVEIN® Event
2022-11-01 Theraclion releases its 2022 semi-annual financial report (in French) Event
2022-09-26 The new strategy is paying off Event
2022-09-26 Half year results 2022 Event
2022-06-13 HIFU and their use in immune-oncology presented at the annual scientific meeting of the society of interventional radiology in Boston Event
2022-04-20 Theraclion announces 1,000th treatment for varicose veins with SONOVEIN ® Event
2022-02-25 Theraclion announces the successful completion of a €6.5 million capital increase Event

Source: https://www.theraclion.com/investors/